88 results
8-K
EX-99.1
APLS
Apellis Pharmaceuticals Inc
27 Feb 24
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
7:30am
taxes
Income tax expense
Net income/(loss)
Other comprehensive (loss)/gain:
Unrealized (loss)/gain on marketable securities
Unrealized (loss)/gain … on pension plans
Foreign currency gain/(loss)
Total other comprehensive income/(loss)
Comprehensive loss, net of tax
Net loss per common share, basic
8-K
EX-1.1
5rnk0mjdcl 7abs19cw
1 Nov 23
Entry into a Material Definitive Agreement
7:59am
424B5
n9y dnzd2uu6cn
1 Nov 23
Prospectus supplement for primary offering
7:51am
8-K
EX-99.1
xhx 1ubjm16xycdsq
31 Jul 23
Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results
8:03am
8-K
EX-10.1
2lz 3et3s
2 Aug 22
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-10.1
0le6d p9p
27 Jul 22
Entry into a Material Definitive Agreement
7:08am
8-K
EX-1.1
4681mhpkbpvnzut8che
24 Mar 22
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8:18pm